Horizant is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Arbor Pharmaceuticals. The primary component is Gabapentin Enacarbil.
Product ID | 53451-0103_2f4916e7-2d50-409a-8978-2d4aaaa99291 |
NDC | 53451-0103 |
Product Type | Human Prescription Drug |
Proprietary Name | Horizant |
Generic Name | Gabapentin Enacarbil |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2013-05-01 |
Marketing Category | NDA / NDA |
Application Number | NDA022399 |
Labeler Name | Arbor Pharmaceuticals |
Substance Name | GABAPENTIN ENACARBIL |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2013-05-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022399 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2013-05-01 |
Marketing Category | NDA |
Application Number | NDA022399 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2013-05-01 |
Ingredient | Strength |
---|---|
GABAPENTIN ENACARBIL | 300 mg/1 |
SPL SET ID: | 4c486fc7-c8c4-4c6c-b30c-366dabaeaadd |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
53451-0101 | Horizant | gabapentin enacarbil |
53451-0103 | Horizant | gabapentin enacarbil |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
HORIZANT 85017223 3992014 Live/Registered |
Horizant Inc. 2010-04-19 |
HORIZANT 78888833 not registered Dead/Abandoned |
Glaxo Group Limited 2006-05-22 |
HORIZANT 77782887 4071035 Live/Registered |
ARBOR PHARMACEUTICALS, LLC 2009-07-16 |
HORIZANT 75871565 not registered Dead/Abandoned |
Staffmark, Inc. 1999-12-14 |